Immunophotonics, Inc.: Clinical Trials

4 trials sponsored by Immunophotonics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1
Phase 13Active not recruiting 1, Completed 1, Recruiting 1
Phase 31Not yet recruiting 1

Follow Immunophotonics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases
Phase 2 / Phase 3Not yet recruitingImmunophotonics, Inc.7172026-05-012026-01-07
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
IP-001 - Colorectal Cancer, Liver Metastases
Phase 1 / Phase 2RecruitingM.R. Meijerink1202024-07-102025-07-03
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
1.0% IP-001 for Injection - Metastatic Solid Tumor, Colon Cancer
Phase 1 / Phase 2Active not recruitingImmunophotonics, Inc.422022-11-292025-01-08
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
IP-001, Thermal Ablation - Advanced Solid Tumors
Phase 1 / Phase 2CompletedSwiss Cancer Institute282020-10-122025-12-30

Conditions studied

Colorectal Neoplasms (2)  ·  Melanoma (2)  ·  Neoplasm Metastasis (2)  ·  Neoplasms (2)  ·  Sarcoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colonic Neoplasms (1)  ·  Rectal Neoplasms (1)

Interventions

N-dihydrogalactochitosan (4)  ·  Injections (2)  ·  Microwaves (1)  ·  Transurethral Resection of Prostate (1)  ·  Water (1)

Countries

Switzerland (2)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Diane Beatty, PhD (1)  ·  Diane M Beatty, PhD (1)  ·  Markus Joerger, MD PhD (1)  ·  Markus Jorger, MD (1)  ·  Martijn R. Meijerink, Prof. (1)

NIH funding

2023 (1), 2025 (1)